City
Epaper

Zydus Cadila receives final approval from USFDA for Glycopyrrolate injection

By ANI | Published: November 10, 2021 2:18 PM

India-based pharma giant, Zydus Cadila received final approval from USFDA for Glycopyrrolate injection that is used before surgery to decrease the volume of secretions from the mouth, lungs and stomach.

Open in App

India-based pharma giant, Zydus Cadila received final approval from USFDA for Glycopyrrolate injection that is used before surgery to decrease the volume of secretions from the mouth, lungs and stomach.

"Zydus Cadila has received final approval from the USFDA to market Glycopyrrolate injection in the strengths of 0.2 mg/mL and 0.4 mg/2 mL (0.2 mg/mL) single-dose vials and 1 mg/5 mL (0.2 mg/mL) and 4 mg/20 mL (0.2 mg/mL) Multiple-Dose Vials, (US RLD: Robinul)," said the official press release by Zydus Cadila.

Glycopyrrolate is used before surgery to decrease the volume of secretions from mouth, lungs and stomach. It can also be used either before or during surgery to maintain heart's normal beating rhythm. It is also used to counter the effects of some other medicines, which can slow heartbeat or produce excessive secretions when used during surgery.

Glycopyrrolate injection can also be used in adults as an adjunctive therapy for the treatment of a gastrointestinal ulcer when a rapid effect is desired or when oral medication is not tolerated. The drug will be manufactured at the group's injectables manufacturing facility at CHL-Jarod, near Vadodara.

The group now has 324 approvals and has so far filed over 400 ANDAs since the commencement of the filing process in FY 2003-04.

ZyCoV-D, developed by Indian vaccine giant Zydus Cadila. The Ahmedabad-based pharma company announced that it received EUA from DCGI for India's second indigenous vaccine, ZyCoV-D on August 20.

It is the world's first plasmid DNA vaccine for COVID-19. ZyCoV-D is a three-dose vaccine that will be administered on day zero, day 28th and then on the 56th day. ZyCoV-D, is a needle-free vaccine administered using the PharmaJet, a needle-free applicator, which ensures painless intradermal vaccine delivery. This is for the first time that a technologically advanced vaccine has been successfully developed on the plasmid DNA platform for human use.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Cadila HealthcareUsfdausVadodaraVadodra municipal corporation
Open in App

Related Stories

NationalVadodara Crime Branch Arrests Two Criminals, Involved in Multiple Criminal Activities

InternationalUS Fire: Over 1.2 Million Chickens Burn to Death in Massive Blaze at Egg Facility in Illinois (Watch Video)

InternationalOhio Chase Bank Blast: One Dead, Multiple Injured After Gas Leak Explosion in Youngstown Building; Dramatic Video Emerges

NationalVadodara: Protest Over Installation of Smart Electricity Meters at the Akota Office of Madhya Gujarat Vij Corporation Limited

MaharashtraGanesh Chaturthi 2024: Pen's Ganpati Bappa Goes Global as Fifth Batch of 5,000 Idols Shipped to Canada and America

National Realted Stories

National2013 killing of 4 cops in Sopore: J&K’s SIA carries out raid in Srinagar city

NationalPM Modi-led new govt to take country closer to 'Vision@2047'

NationalCanadian MP Arya hits out at Khalistani supporters for mocking PM Indira Gandhi’s assassination

National'Extremely saddening': PM Modi expresses condolences over Ramoji Rao's demise

NationalDelhi Fire: Blaze at Narela Food Processing Unit Kills 3, Injures 6